Harrison G. Zhang

The Virtual Biotech uses AI agents to integrate multi-omic and clinical data for drug discovery, identifying genomic features linked to trial success and proposing therapeutic strategies.

Eubiota enables autonomous discovery in the gut microbiome by integrating modular agents and reinforcement learning, identifying key pathways and designing therapeutic interventions.

The paper examines differential associations of the IL6R variant across genetic ancestries and identifies trait differences that may inform targeted therapies.